Auf dieser Seite
DXCM DexCom, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 30, 2026
$85,36
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$54,1152-Wochen-Tief
$92,5952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Umsatz (TTM)
$4.97B
Ihre Abzeichen
52W-Spanne
$54–$93
Analystenbewertung
BUY
Kursziel
$95
P/E
33.9
ROE
38.5%
Nettogewinnmarge
20.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DXCM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$85.36
Marktkapitalisierung (MRQ)
$32.21B
P/E (TTM)
33.9
EPS (TTM)
$2.52
Umsatz (TTM)
$4.97B
ROE (TTM)
38.5%
52W-Spanne
$54–$93
DXCM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 13. Juni 2022 | 4-for-1 | Vorwärts |
Über DexCom, Inc. - Common Stock Unternehmensübersicht von Wikipedia
DexCom, Inc. ist ein US-amerikanisches Unternehmen, das kontinuierlich messende Glucosesensoren für Diabetes-Patienten entwickelt, herstellt und vertreibt. Der Hauptsitz befindet sich in San Diego.
## Geschichte
Dexcom wurde 1999 von Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston und Bret Megargel gegründet. 2006 erhielt Dexcom von der Food and Drug Administration die Genehmigung für ein System zur kontinuierlichen Glucosemessung, das drei Tage lang alle 24 Stunden bis zu 288 Werte liefert. Die Zulassung für die zweite Generation, die sieben Tage lang Werte liefert, erfolgte im Mai 2007.
2008 kündigte Dexcom an, mit Insulet Corporation, Animas Corporation und Edwards Lifesciences zusammenzuarbeiten, um einen kontinuierlich messenden Glucosesensor für Intensivstationen zu entwickeln. Im Jahr 2013 wurde die Zusammenarbeit mit Insulet beendet.
Um die Kompatibilität der neuen Generation G5 und G6 mit den Insulinpumpen von Tandem herzustellen, wurde 2015 ein Vertrag mit Tandem Diabetes Care abgeschlossen. Die Zulassung der Geräte erfolgte 2016 und 2018.
Im Mai 2020 schloss Dexcom einen Partnerschaftsvertrag mit der Schweizer Firma Ypsomed. Die Zusammenarbeit erlaubt den Betrieb der Insulinpumpe mylife von Ypsomed mit dem CGM-System (Kontinuierlich messender Glucosesensor) G6 von Dexcom in einem Closed-Loop-Betrieb. Im März 2022 erhielt der Blutglucose-Sensor G7 eine CE-Zulassung.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter11.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4.66B2016-12-31 → 2025-12-31
EPS$2.092017-12-31 → 2025-12-31
Freier Cashflow$1.08B2016-12-31 → 2025-12-31
Nettogewinnmarge20.1%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DXCM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 33.95-Jahres-Durchschnitt ≈114.7 | ≈114.7 | 28.0 | Fairer Wert | |
| P/S (TTM) | 6.55-Jahres-Durchschnitt ≈9.3 | ≈9.3 | 4.8 | Überbewertet | |
| K/B (MRQ) | 12.35-Jahres-Durchschnitt ≈14.6 | ≈14.6 | 4.7 | Überbewertet | |
| Kurs / FCF (TTM) | 22.95-Jahres-Durchschnitt ≈110.6 | ≈110.6 | · | · | |
| Kurs / Cashflow (TTM) | 18.45-Jahres-Durchschnitt ≈41.4 | ≈41.4 | 21.9 | Unterbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 12.85-Jahres-Durchschnitt ≈15.9 | ≈15.9 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈3.6 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DXCM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 62.5%5-Jahres-Durchschnitt ≈63.4% | ≈63.4% | 64.0% | Schwach | |
| Betriebsgewinnmarge (TTM) | 22.9%5-Jahres-Durchschnitt ≈15.0% | ≈15.0% | 23.0% | Im Einklang | |
| EBITDA-Marge (TTM) | 28.2%5-Jahres-Durchschnitt ≈20.1% | ≈20.1% | 27.1% | Im Einklang | |
| Vorgewinnmarge (TTM) | 25.8%5-Jahres-Durchschnitt ≈16.2% | ≈16.2% | 21.6% | Im Einklang | |
| Nettogewinnmarge (TTM) | 20.1%5-Jahres-Durchschnitt ≈13.0% | ≈13.0% | 15.3% | Spitzenklasse | |
| ROA (TTM) | 14.5%5-Jahres-Durchschnitt ≈8.3% | ≈8.3% | 7.5% | Spitzenklasse | |
| ROE (TTM) | 38.5%5-Jahres-Durchschnitt ≈21.9% | ≈21.9% | 14.1% | Spitzenklasse | |
| ROIC | 25.5%5-Jahres-Durchschnitt ≈19.4% | ≈19.4% | 9.9% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DXCM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.75-Jahres-Durchschnitt ≈2.7 | ≈2.7 | 1.5 | Im Einklang | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 0.8 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | DXCM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 15.6%5-Jahres-Durchschnitt ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 17.0%5-Jahres-Durchschnitt ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 19.3% | · | · | · | |
| EPS YoY (EPS VjV) | 47.2%5-Jahres-Durchschnitt ≈21.9% | ≈21.9% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 45.1%5-Jahres-Durchschnitt ≈21.4% | ≈21.4% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 36.6%5-Jahres-Durchschnitt ≈24.9% | ≈24.9% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 9.5% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 34.8%5-Jahres-Durchschnitt ≈24.3% | ≈24.3% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 8.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | DXCM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.75-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.5 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 3.25-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 2.4 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 4.25-Jahres-Durchschnitt ≈4.5 | ≈4.5 | 6.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$423.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
9.1%
Nächster Bericht
Okt 28, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 28, 2026 | $0.70 | $0.62 | 12.4% |
| 31. März 2026 | $0.56 | $0.48 | 17.0% | |
| 31. Dezember 2025 | $0.56 | $0.48 | 17.0% | |
| 30. September 2025 | $0.61 | $0.58 | 5.3% | |
| 30. Juni 2025 | $0.48 | $0.45 | 6.8% | |
| 31. März 2025 | $0.32 | $0.33 | -4.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.14 | $5.38 | $5.37 | $5.52 | $23.21 | $19.01 | $9.64 | $7.37 | $4.82 | $3.35 | $2.71 | $1.81 | |
| Revenue / Share | $11.50 | $9.77 | $8.51 | $6.81 | $24.46 | $19.76 | $15.99 | · | · | · | · | · | |
| Cash Flow / Share | $3.55 | $2.40 | $1.76 | $1.57 | $4.42 | $4.88 | $3.41 | · | · | · | · | · | |
| Cash / Share | $2.38 | $1.55 | $1.47 | $1.66 | $10.85 | $8.51 | $4.87 | $12.63 | $5.07 | $1.12 | $1.05 | $0.93 | |
| EPS (TTM) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | · | 391,100,000 | 392,100,000 | 391,100,000 | · | 394,200,000 | 399,200,000 | 390,200,000 | · | 386,600,000 | 386,700,000 | 386,700,000 | · | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | · | 407,400,000 | 408,200,000 | 407,500,000 | · | 410,200,000 | 416,800,000 | 416,700,000 | · | 426,800,000 | 431,500,000 | 418,500,000 | · | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.95 | $7.66 | · | $6.99 | $6.56 | $5.78 | · | $5.07 | $6.08 | $5.67 | · | $5.87 | $5.44 | $5.76 | · | $4.72 | |
| Revenue / Share | $3.35 | $3.03 | · | $2.97 | $2.83 | $2.54 | · | $2.42 | $2.41 | $2.21 | · | $2.28 | $2.02 | $1.77 | · | $1.81 | |
| Cash Flow / Share | · | $1.34 | · | · | · | $0.45 | · | · | · | $0.50 | · | · | · | $0.37 | · | · | |
| Cash / Share | $2.93 | $2.90 | · | $4.71 | $2.96 | $2.31 | · | $1.59 | $2.34 | $2.15 | · | $1.67 | $3.09 | $1.61 | · | $1.81 | |
| EPS (TTM) | $2.52 | $2.33 | · | $1.79 | $1.43 | $1.33 | · | $1.66 | $1.61 | $1.54 | · | $0.92 | $0.87 | $0.71 | · | $0.16 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.97B | $4.82B | · | $4.52B | $4.30B | $4.15B | · | $3.95B | $3.93B | $3.80B | · | $3.40B | $3.20B | $3.02B | · | $2.79B | |
| Net Income TTM | $1000M | $930M | · | $721M | $572M | $535M | · | $681M | $667M | $639M | · | $377M | $358M | $292M | · | $244M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 26.7 | 27.0 | · | 37.6 | 61.0 | 51.3 | · | 40.4 | 70.4 | 90.1 | · | 101.4 | 147.7 | 163.6 | · | 503.4 | |
| P/S | 5.1 | 5.0 | · | 5.8 | 8.0 | 6.5 | · | 6.6 | 11.5 | 14.5 | · | 10.6 | 15.5 | 14.9 | · | 11.1 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| Earnings Yield | 3.7% | 3.7% | · | 2.7% | 1.6% | 1.9% | · | 2.5% | 1.4% | 1.1% | · | 0.99% | 0.68% | 0.61% | · | 0.20% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Bruttogewinnmarge % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Betriebsgewinnmarge % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Nettoergebnis | $836M | $576M | $542M | $341M | $217M |
| Verwässerte EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $1.08B | $631M | $512M | $305M | $53M |
Institutionelle Eigentümer (13F) 1.078 Einreicher · $29.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
1.078
Gehaltener Wert
$29.5B
Neue Positionen
125
Geschlossene Positionen
97
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 125 (-42 vs. Vorquartal) | 97 (+5 vs. Vorquartal) | 401 (+31 vs. Vorquartal) | 365 (+14 vs. Vorquartal) | +13.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.257.066.468 | 49.074.378 | 11,03% | Aktien |
| BlackRock, Inc. | $2.575.742.626 | 38.244.137 | 8,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.697.876.797 | 25.209.752 | 5,75% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.323.867.969 | 19.656.540 | 4,48% | Aktien |
| STATE STREET CORP | $1.237.947.284 | 18.380.806 | 4,19% | Aktien |
| Invesco Ltd. | $1.029.655.765 | 15.288.133 | 3,49% | Aktien |
| BAILLIE GIFFORD & CO | $996.887.087 | 14.801.590 | 3,38% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $834.165.910 | 12.426.515 | 2,83% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $734.346.085 | 11.693.409 | 2,49% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $612.059.728 | 9.746.174 | 2,07% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $574.325.172 | 8.527.471 | 1,95% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462.914.937 | 6.873.273 | 1,57% | Aktien |
| NORGES BANK | $462.565.862 | 6.868.090 | 1,57% | Aktien |
| UBS Group AG | $408.530.217 | 6.065.779 | 1,38% | Aktien |
| Amundi | $377.395.039 | 5.603.490 | 1,28% | Aktien |
| MORGAN STANLEY | $347.275.842 | 5.156.282 | 1,18% | Aktien |
| AMERIPRISE FINANCIAL INC | $324.681.713 | 4.820.775 | 1,10% | Aktien |
| Castle Hook Partners LP | $260.667.534 | 3.870.342 | 0,88% | Aktien |
| GOLDMAN SACHS GROUP INC | $253.142.816 | 3.758.616 | 0,86% | Aktien |
| FRANKLIN RESOURCES INC | $242.183.395 | 3.595.893 | 0,82% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $240.915.152 | 3.560.621 | 0,82% | Aktien |
| CIBC Bancorp USA Inc. | $232.974.509 | 3.454.735 | 0,79% | Aktien |
| JPMORGAN CHASE & CO | $232.690.154 | 3.325.095 | 0,79% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231.627.696 | 3.439.164 | 0,78% | Aktien |
| NORTHERN TRUST CORP | $221.927.948 | 3.295.144 | 0,75% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $218.060.428 | 3.237.720 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $213.068.756 | 3.163.604 | 0,72% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $207.976.113 | 3.087.990 | 0,70% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $206.860.340 | 3.071.423 | 0,70% | Aktien |
| CIBC Private Wealth Group LLC | $195.665.945 | 2.907.801 | 0,66% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $183.859.102 | 2.729.905 | 0,62% | Aktien |
| Legal & General Group Plc | $173.237.203 | 2.572.193 | 0,59% | Aktien |
| JANUS HENDERSON GROUP PLC | $166.077.317 | 2.644.539 | 0,56% | Aktien |
| DEUTSCHE BANK AG\ | $164.034.901 | 2.435.559 | 0,56% | Aktien |
| Bank of New York Mellon Corp | $155.554.805 | 2.309.648 | 0,53% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $152.790.681 | 2.268.607 | 0,52% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $149.327.006 | 2.217.179 | 0,51% | Aktien |
| Employees Provident Fund Board | $147.498.453 | 2.190.029 | 0,50% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $142.152.983 | 2.109.812 | 0,48% | Aktien |
| ROYAL BANK OF CANADA | $137.011.000 | 2.034.290 | 0,46% | Aktien |
| FMR LLC | $127.510.091 | 1.893.246 | 0,43% | Aktien |
| Nuveen, LLC | $123.266.328 | 1.830.235 | 0,42% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $117.263.085 | 1.741.100 | 0,40% | Verkaufsoption |
| NOMURA HOLDINGS INC | $115.126.069 | 1.709.370 | 0,39% | Aktien |
| AXA Investment Managers S.A. | $112.203.653 | 1.667.464 | 0,38% | Aktien |
| BLAIR WILLIAM & CO/IL | $112.182.565 | 1.665.665 | 0,38% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $109.834.111 | 1.630.796 | 0,37% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $92.130.221 | 1.367.932 | 0,31% | Aktien |
| DSM CAPITAL PARTNERS LLC | $91.537.742 | 1.359.135 | 0,31% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89.939.931 | 1.335.411 | 0,30% | Aktien |
Unternehmensinsider 61 Insider · 37 Führungskräfte · 26 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | 22. August 2026 F | 418.908 | 2 | 0 | $1.001.761 |
| Andrew P Rasdal | President & CEO | 2. Mai 2006 M | 2.944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | 22. März 2017 S | 8.452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | 15. Mai 2007 A | 26.255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | 10. September 2021 S | 19.280 | 0 | 0 | $0 |
| Sadie Stern | EVP Chief People & Culture Off | 28. September 2026 S | 123.478 | 0 | 2 | $-447.644 |
| Michael Jon Brown | EVP Chief Legal Compliance Off | 15. September 2026 S | 99.885 | 0 | 7 | $-873.358 |
| Jereme M Sylvain | EVP, Chief Financal Officer | 10. September 2026 S | 146.828 | 0 | 1 | $-302.936 |
| Kevin R Sayer | Executive Chair | 20. August 2026 S | 302.214 | 0 | 6 | $-8.303.410 |
| Jon Coleman | EVP, Chief Commercial Officer | 4. Juni 2026 S | 95.450 | 0 | 2 | $-722.628 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | 29. Januar 2025 S | 42.044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | 12. März 2024 S | 66.641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | 18. Dezember 2023 D | 48.949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | 18. Dezember 2023 D | 58.469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | 24. November 2023 S | 124.775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | 9. November 2023 S | 47.725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | 11. September 2023 D | 48.453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | 10. März 2023 D | 208.023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | 10. März 2023 D | 50.908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | 9. Mai 2022 S | 13.675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | 9. März 2022 D | 13.789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | 9. September 2021 S | 16.254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | 23. März 2021 S | 6.654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | 9. September 2020 D | 34.784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | 11. März 2020 S | 38.584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | 16. Juli 2018 S | 50.882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | 9. März 2017 M | 84.034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | 16. November 2010 P | 3.387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | 16. August 2010 A | · | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | 12. März 2010 A | · | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | 12. März 2010 A | · | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | 12. März 2010 A | 18.741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | 19. Mai 2008 A | · | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | 24. März 2008 A | 53.125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | 2. November 2007 A | 10.967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | 2. August 2007 A | · | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | 9. März 2007 A | · | 0 | 0 | $0 |
| Nicholas Augustinos | Direktor | 15. September 2026 S | 29.293 | 0 | 2 | $-679.769 |
| Glenn S Boehnlein | Direktor | 10. September 2026 A | 5.841 | 0 | 0 | $0 |
| Bridgette P Heller | Direktor | 12. August 2026 S | 29.570 | 0 | 4 | $-277.672 |
| Mark G Foletta | Direktor | 3. August 2026 S | 48.852 | 0 | 4 | $-627.183 |
| Albert Frederick Osterloh IV | Direktor | 28. Mai 2026 A | 8.691 | 0 | 0 | $0 |
| Euan A. Ashley | Direktor | 28. Mai 2026 A | 12.731 | 0 | 0 | $0 |
| Rimma Driscoll | Direktor | 28. Mai 2026 A | 17.319 | 0 | 0 | $0 |
| Kyle Malady | Direktor | 28. Mai 2026 A | 28.242 | 0 | 0 | $0 |
| Richard Alexander Collins | Direktor | 28. Mai 2026 A | 5.605 | 0 | 2 | $-389.410 |
| Renee D Gala | Direktor | 28. Mai 2026 A | 12.486 | 0 | 0 | $0 |
| Steven R Altman | Direktor | 28. Mai 2026 A | 5.565 | 0 | 0 | $0 |
| Karen M Dahut | Direktor | 8. Mai 2025 G | 17.779 | 0 | 0 | $0 |
| Eric Topol | Direktor | 8. Mai 2025 G | 380.545 | 0 | 0 | $0 |
| Barbara Kahn | Direktor | 18. Mai 2024 G | 22.575 | 0 | 0 | $0 |
| Jay S Skyler | Direktor | 18. Mai 2023 G | 63.348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Direktor | 1. September 2016 S | 52.820 | 0 | 0 | $0 |
| Martin Doordan | Direktor | 1. Juni 2012 A | 39.633 | 0 | 0 | $0 |
| Donald A Lucas | Direktor | 19. Mai 2010 A | 16.448 | 0 | 0 | $0 |
| Donald L Lucas | Direktor | 15. März 2010 S | 69.076 | 0 | 0 | $0 |
| Sean Carney | Direktor | 19. Mai 2008 A | 20.285 | 0 | 0 | $0 |
| Glen D Nelson | Direktor | 14. März 2008 P | 170.654 | 0 | 0 | $0 |
| Kim D Blickenstaff | Direktor | 23. Mai 2007 A | 4.104 | 0 | 0 | $0 |
| Brenton Karl Ahrens | Direktor | 13. April 2006 A | 280.619 | 0 | 0 | $0 |
| Jorge A Valdes | · | 13. März 2017 S | 10.442 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 133 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 4,91% | 1.844.741 SH | 11. September 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 2,74% | 7.762 NS | 31. Juli 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 2,12% | 527 NS | 31. Juli 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2,04% | 4.976 NS | 31. Juli 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,96% | 948 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,70% | 171.659 SH | 2. Oktober 2026 | Täglich |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,58% | 373.925 SH | 2. Oktober 2026 | Täglich |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 1,28% | 17.329 NS | 31. Juli 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,15% | 305.526 NS | 31. Juli 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 1,15% | 184.331 NS | 31. Juli 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,01% | 5.118 NS | 31. Juli 2026 | N-PORT |
| IWP · iShares Trust | 0,95% | 2.162.676 SH | 11. September 2026 | Täglich |
| QFLR · Innovator ETFs Trust | 0,93% | 58.151 NS | 31. Juli 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,81% | 20.420 NS | 31. Juli 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,81% | 3.979 NS | 31. Juli 2026 | N-PORT |
| QNXT · iShares Trust | 0,62% | 2.014 SH | 11. September 2026 | Täglich |
| SDG · iShares Trust | 0,60% | 11.793 SH | 11. September 2026 | Täglich |
| VOT · VANGUARD INDEX FUNDS | 0,57% | 2.956.203 SH | 19. August 2026 | Täglich |
| PDP · Invesco Exchange-Traded Fund Trust | 0,57% | 97.454 SH | 2. Oktober 2026 | Täglich |
| QIDX · Spinnaker ETF Series | 0,55% | 2.575 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,52% | 65.774 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,52% | 224.542 SH | 11. September 2026 | Täglich |
| COWZ · Pacer Funds Trust | 0,49% | 1.097.680 NS | 31. Juli 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 76.326 NS | 31. Juli 2026 | N-PORT |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,48% | 1.038.926 SH | 2. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,46% | 183.141 NS | 31. Juli 2026 | N-PORT |
| IMCG · iShares Trust | 0,45% | 213.189 SH | 11. September 2026 | Täglich |
| IXJ · iShares Trust | 0,41% | 203.560 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,38% | 1.156.710 SH | 19. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,37% | 7.593 NS | 31. Juli 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,34% | 23.742 SH | 19. August 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,27% | 187.634 NS | 31. Juli 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,25% | 8.362.213 SH | 19. August 2026 | Täglich |
| SIZE · iShares Trust | 0,24% | 12.297 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 16.587 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,24% | 1.572.597 SH | 11. September 2026 | Täglich |
| IMCB · iShares Trust | 0,23% | 45.160 SH | 11. September 2026 | Täglich |
| ESUM · Strategy Shares | 0,23% | 4.954 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.329.076 SH | 2. Oktober 2026 | Täglich |
| ESLG · Strategy Shares | 0,20% | 561 NS | 31. Juli 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,19% | 43.412 SH | 11. September 2026 | Täglich |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 181.851 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,18% | 485 SH | 11. September 2026 | Täglich |
| LRND · New York Life Investments ETF Trust | 0,18% | 8.712 NS | 31. Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,15% | 23.840 NS | 31. Juli 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 2.837 NS | 31. Juli 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,15% | 21.359 NS | 31. Juli 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 136 NS | 31. Juli 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,15% | 895 NS | 31. Juli 2026 | N-PORT |
| QYLD · Global X Funds | 0,15% | 141.287 NS | 31. Juli 2026 | N-PORT |
| QCLR · Global X Funds | 0,14% | 57 NS | 31. Juli 2026 | N-PORT |
| QRMI · Global X Funds | 0,14% | 246 NS | 31. Juli 2026 | N-PORT |
| QQQM · Invesco Exchange-Traded Fund Trust … | 0,14% | 1.735.537 SH | 2. Oktober 2026 | Täglich |
| QQQ · Invesco QQQ Trust, Series 1 | 0,14% | 7.901.347 SH | 2. Oktober 2026 | Täglich |
| QSIX · Pacer Funds Trust | 0,14% | 298 NS | 31. Juli 2026 | N-PORT |
| USXF · iShares Trust | 0,13% | 22.924 SH | 11. September 2026 | Täglich |
| QUAL · iShares Trust | 0,12% | 666.753 SH | 11. September 2026 | Täglich |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,11% | 20.921 NS | 31. Juli 2026 | N-PORT |
| GARP · iShares Trust | 0,11% | 40.229 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,11% | 7.089 NS | 31. Juli 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,11% | 10.730 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,10% | 56.316 SH | 2. Oktober 2026 | Täglich |
| ILCG · iShares Trust | 0,10% | 37.554 SH | 11. September 2026 | Täglich |
| AQLT · iShares Trust | 0,10% | 3.937 SH | 11. September 2026 | Täglich |
| IQSU · New York Life Investments ETF Trust | 0,10% | 3.878 NS | 31. Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,10% | 1.441.625 SH | 11. September 2026 | Täglich |
| CHRI · Global X Funds | 0,10% | 93 NS | 31. Juli 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 8.945 SH | 2. Oktober 2026 | Täglich |
| DSI · iShares Trust | 0,09% | 58.749 SH | 11. September 2026 | Täglich |
| VUG · VANGUARD INDEX FUNDS | 0,09% | 4.943.048 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,09% | 499.383 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,09% | 23.598 NS | 31. Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 603.971 SH | 19. August 2026 | Täglich |
| WRND · New York Life Investments ETF Trust | 0,08% | 100 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,08% | 31.150 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,08% | 20 NS | 31. Juli 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,08% | 10 NS | 31. Juli 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,06% | 12.050 SH | 2. Oktober 2026 | Täglich |
| TOPC · iShares Trust | 0,06% | 230 SH | 11. September 2026 | Täglich |
| XVV · iShares Trust | 0,06% | 4.446 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,06% | 333 NS | 31. Juli 2026 | N-PORT |
| XTR · Global X Funds | 0,06% | 32 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,05% | 23 NS | 31. Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,05% | 312.923 SH | 11. September 2026 | Täglich |
| XYLG · Global X Funds | 0,05% | 394 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,05% | 19.868 NS | 31. Juli 2026 | N-PORT |
| IUSV · iShares Trust | 0,05% | 165.780 SH | 11. September 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,05% | 66.881 SH | 2. Oktober 2026 | Täglich |
| PBP · Invesco Exchange-Traded Fund Trust | 0,05% | 2.246 SH | 2. Oktober 2026 | Täglich |
| TOV · EA Series Trust | 0,05% | 1.441 NS | 31. Juli 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,05% | 912 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,05% | 32.725 NS | 31. Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 53.113 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,05% | 19.478 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,05% | 4.868.303 SH | 11. September 2026 | Täglich |
| DFVX · Dimensional ETF Trust | 0,05% | 3.126 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,05% | 6.516 NS | 31. Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,05% | 7.544 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,05% | 120.564 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.347 SH | 2. Oktober 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,05% | 33 NS | 31. Juli 2026 | N-PORT |
| IVW · iShares Trust | 0,05% | 421.263 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,05% | 16.523 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,05% | 264.795 SH | 11. September 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,05% | 1.456 NS | 31. Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,05% | 9.285 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,05% | 67.183 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,04% | 173.802 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,04% | 499.542 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,04% | 104.639 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,04% | 297 SH | 2. Oktober 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,04% | 10.024.256 SH | 19. August 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,04% | 450.660 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,04% | 12.252.641 SH | 19. August 2026 | Täglich |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,04% | 146.079 SH | 19. August 2026 | Täglich |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 43.354 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,04% | 63.234 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,04% | 32.310 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,04% | 86.728 SH | 19. August 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,04% | 2.682 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,04% | 1.068 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,04% | 30.165 NS | 31. Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,04% | 34.971 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 8.908 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 121.058 SH | 11. September 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,03% | 29.507 SH | 2. Oktober 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 28.890 SH | 2. Oktober 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 323.858 SH | 19. August 2026 | Täglich |
| DYNF · BlackRock ETF Trust | 0,02% | 87.332 SH | 11. September 2026 | Täglich |
| USCL · iShares Trust | 0,02% | 5.063 SH | 11. September 2026 | Täglich |
| LGDX · Tidal Trust III | 0,01% | 229 NS | 31. Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,01% | 1.408 SH | 11. September 2026 | Täglich |
| PEVC · Pacer Funds Trust | 0,00% | 1 NS | 31. Juli 2026 | N-PORT |
DXCM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 36 Analysten
KAUF
Median-Ziel
$95.00
+11,3%
15 41,7%
Starker Kauf
16 44,4%
Kauf
5 13,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
25 Analysten · 2026-10-02Mittelwert-Ziel $95.08 +11,4%
Jetzt
Aktueller Preis $85.36
Tief$79.00
Mittelwert$95.08
Hoch$115.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | · | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | · | 25.3 | 8.2% | 7.7% | 6.5% | · |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
DexCom (DXCM) meldet optimistische Prognose für 2026 und steigt um 6,6 %
Yahoo Finance · 4 Monate, 2 Wochen vor
Sind Wall Street-Analysten optimistisch für die Aktie von DexCom?
Yahoo Finance · 4 Monate, 2 Wochen vor
DexCom (DXCM) meldet Umsatz von 1,19 Mrd. USD für Q1 2026 mit 15% Wachstum
Yahoo Finance · 4 Monate, 3 Wochen vor
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,92
Einstieg
$64.82
R:R 1,92
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 1,85
Einstieg
$65.02
R:R 1,85
RANGE
Stop-Loss ausgelöst
Risiko 1
Belohnung 4,99
Einstieg
$63.32
R:R 4,99
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 30, 2026